Lycia Therapeutics Inc. (LYCA )

Currency in USD Disclaimer
$25.05 -$1.06 (-4.06%)
Closed 10/28/2026
$24.03
$26.48
$22.19
$36.49

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol LYCA
  • Company Lycia Therapeutics Inc.
  • Price $25.05
  • Changes Percentage -4.06
  • Change -1.06
  • Day Low $24.03
  • Day High $26.48
  • Year High $36.49
  • Year Low $22.19
  • Market Cap $1,562,836,770
  • Price Avg 50 EMA (D) $30
  • Price Avg 200 EMA (D) $30
  • Exchange NASDAQ
  • Volume 2,280,584
  • Average Volume 2,284,000
  • Open $26.48
  • Previous Close $26.11
  • EPS 0
  • PE 0.00
  • Earnings Announcement 1970-01-01 00:00:00
  • Shares Outstanding $52,094,559

Company brief: LYCIA THERAPEUTICS INC. (LYCA )

Lycia Therapeutics, Inc. operates as a clinical-stage biotechnology company. It engages in the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory, and allergic diseases. The company was founded in 2019 and is headquartered in South San Francisco, CA.

LYCA Corporation News

Income Statement